Foundation ups IPO target
This article was originally published in Clinica
Executive Summary
Hoping to buck the trend for lackluster medtech IPOs, molecular diagnostics specialist Foundation Medicine has increased its flotation target to up to $92m. Earlier this year, the firm said it was planning to raise up to $86m by going public on the Nasdaq Global Market under the ticker symbol FMI (www.clinica.co.uk, 30 July 2013).